CellCarta Launched Global Digital Pathology and AI Consortium for Precision Medicine

Consortium initially brings together Lunit, Mindpeak, Imagene AI, Dipath AI, Nucleai, Tivenix and Indica Labs to give biopharma sponsors a single CRO-led...

July 17, 2026 | Friday | News
Primrose Bio Secured $2 Million NIH Grant to Advance DNA- and RNA-Based Medicine Research

$2 million grant builds on research to develop sequence elements that improve DNA- and RNA-based medicine efficacy Primrose Bio, Inc., a company with pr...

July 17, 2026 | Friday | News
CPC Biotech Introduced RevolveSD™ Series for Faster Sterile Single-Use Bioprocess Disconnections

CPC Biotech, part of PSG and Dover (NYSE: DOV) and a leading manufacturer of connectors, pumps, and flow sensors used in biopharmaceu...

July 17, 2026 | Friday | News
AI, Leadership, and the Future of Pharmaceutical Innovation

  As artificial intelligence and advanced technologies transform the pharmaceutical industry, leaders face the challenge of harnessing innovation wit...

July 16, 2026 | Thursday | Interaction
Nucs AI Partners with Segmed to Advance AI Validation in Precision Oncology

Partnership combines large-scale real-world imaging and clinical data with advanced AI capabilities to accelerate biomarker development, real-world evi...

July 16, 2026 | Thursday | News
Sapphiros Secures BARDA-Backed RRPV Agreement to Advance Portable Molecular Diagnostics

Multi-year program supports development of disposable molecular diagnostic platforms for point-of-care, field-use, and emergency response settings  ...

July 16, 2026 | Thursday | News
Leica Biosystems to Acquire StatLab Medical Products to Expand Pathology Diagnostics Portfolio

Leica Biosystems, an operating company of Danaher (the "Company"), and a global leader in anatomic pathology solutions advancing precision cancer diagnosti...

July 16, 2026 | Thursday | News
Eurofarma Files for Brazilian Approval of Bavarian Nordic’s Chikungunya Vaccine

Bavarian Nordic A/S (announced that its partner, Eurofarma, has submitted a marketing authorization application to the Brazilian Health Regulatory Agency...

July 15, 2026 | Wednesday | News
Mesoblast Completes Target Enrollment in Phase 3 Trial of Rexlemestrocel-L for Chronic Low Back Pain

Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases,  announced that it has achieved ...

July 15, 2026 | Wednesday | News
Zelluna Doses First Patient in Phase 1 Trial of ZI-MA4-1 TCR-NK Cell Therapy

First patient dosed with ZI-MA4-1 in the ZIMA-101 Phase 1 trial at The Christie NHS Foundation Trust ZI-MA4-1 is the world’s first MAGE-A4-targe...

July 15, 2026 | Wednesday | News
Sanofi Wins FDA Approval for Subcutaneous Sarclisa Escena with On-Body Injector

Sanofi’s subcutaneous Sarclisa Escena approved in the US as first anticancer treatment administered via on-body injector Sarclisa Escena admini...

July 14, 2026 | Tuesday | News
Elevar Therapeutics Receives FDA Complete Response Letter for Rivoceranib-Camrelizumab NDA

Elevar Therapeutics, Inc., a majority-owned subsidiary of HLB Co., Ltd. and a fully integrated biopharmaceutical company dedicated to elevating treatment...

July 14, 2026 | Tuesday | News
Inside BriaCell's Vision for Transforming Cancer Treatment Through Immunotherapy

BriaCell is advancing a new generation of cancer immunotherapies designed to improve outcomes for patients with metastatic breast cancer and other solid tu...

July 14, 2026 | Tuesday | Interview
Warburg Pincus Set to Acquire Pantherx Rare in Deal Valued at Over US$7 Billion

Private equity firm Warburg Pincus is reportedly close to acquiring Pantherx Rare, a leading US specialty pharmacy focused on rare and orphan diseases, in ...

July 13, 2026 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close